Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is -6.84% vs 4.38% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is -15.69% vs -19.46% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is -25.03% vs -6.04% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is -9.33% vs -40.64% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025
Compare Quarterly Results Of Vidipha Central Pharmaceutical JSC With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is 24.92% vs -56.27% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -6.84% vs 4.38% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -38.97% vs 62.84% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -15.69% vs -19.46% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is -49.98% vs 113.67% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -25.03% vs -6.04% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is -3.39% vs -25.47% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -9.33% vs -40.64% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025






